Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Expert Curation of Somatic Variants in Hematological Malignancies By the Clingen Somatic Hematological Cancer Taskforce (ClinGen HCT)

Blood (2020) 136 (Supplement 1): 23.

https://doi.org/10.1182/blood-2020-143028

Published: 2020

Journal Articles

Comparative Genomic Analyses Defines Shared and Unique Features of cHL and PMBL and New Mechanisms of Sensitivity to PD-1 Blockade

Blood (2019) 134 (Supplement_1): 1493.

https://doi.org/10.1182/blood-2019-131904

Published: 2019

Journal Articles

Comprehensive Evaluation and Validation of a Next-Generation Sequencing Assay for Minimal Residual Disease Detection in T-Lymphoblastic Leukemia/Lymphoma

Chang Xu, Ally Studer, Xueyan Chen, MD, Eric Hoyle, David Wu, MD PhD, Zhengwei Mao, Brent L Wood, MD PhD

Blood (2019) 134 (Supplement_1): 1475.

https://doi.org/10.1182/blood-2019-131360

Published: 2019

Journal Articles

Myeloid Malignancy Variant Curation Expert Panel: An ASH-Sponsored Clingen Expert Panel to Optimize and Validate Acmg/AMP Variant Interpretation Guidelines for Genes Associated with Inherited Myeloid Neoplasms

Blood (2018) 132 (Supplement 1): 5849.

https://doi.org/10.1182/blood-2018-99-118979

Published: 2018

Journal Articles

Comprehensive Genomic Analysis of Flow-Sorted Hodgkin Reed Sternberg Cells Reveals Additional Genetic Bases of Immune Evasion

Kirsty Wienand, PhD, Bjoern Chapuy, MDPhD, Chip Stewart, PhD, Andrew Dunford, MS, David Wu, MD PhD, Jaegil Kim, PhD, Atanas Kamburov, PhD, Fathima Zumla Cader, MD PhD MRCP, Matthew D. Ducar, MS, Aaron R. Thorner, PhD, Alexander T Heubeck, BS, Michael J Buonopane, BS, Philippe Armand, MD PhD, Scott J Rodig, MD, Jonathan R. Fromm, MD PhD, Gad Getz, PhD, Margaret A. Shipp, MD

Blood (2018) 132 (Supplement 1): 1559.

https://doi.org/10.1182/blood-2018-99-118453

Published: 2018

Journal Articles

Significance of Peri-Transplant Measurable Residual Disease Detected By Multiparameter Flow Cytometry and Next-Generation Sequencing in Adults with NPM1 -Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Yi Zhou, MD, Megan Othus, PhD, Elihu H. Estey, MD, Roland B. Walter, MD PhD, David Wu, MD PhD, Brent Wood, MDPhD

Blood (2017) 130 (Supplement 1): 2701.

https://doi.org/10.1182/blood.V130.Suppl_1.2701.2701

Published: 2017

Journal Articles

Detection of Mutations in Inherited Bone Marrow Failure and Myelodysplastic Syndrome Genes Using Genomic Capture and Massively Parallel Sequencing in Clinical Diagnostics

Siobán B. Keel, MD, Tom Walsh, PhD, Colin Pritchard, MD, Akiko Shimamura, MD PhD, Mary-Claire King, PhD, David Wu, MD PhD

Blood (2016) 128 (22): 1507.

https://doi.org/10.1182/blood.V128.22.1507.1507

Published: 2016

Journal Articles

Residual Disease Monitoring By High Throughput Sequencing Provides Risk Stratification in Childhood B-ALL and Identifies a Novel Subset of Patients Having Poor Outcome

Brent L. Wood, MD PhD, David Wu, MD PhD, Ilan M. Kirsch, MD, Beryl Crossley, BS, David Williamson, Charles Gawad, MD, Michael J. Borowitz, MD PhD, Meenakshi Devidas, PhD, Kelly W. Maloney, MD, Eric Larsen, MD, Naomi Winick, MD, Elizabeth Raetz, MD, William L. Carroll, MD, Stephen P. Hunger, MD, Mignon L. Loh, MD, Harlan Robins, PhD

Blood (2016) 128 (22): 1086.

https://doi.org/10.1182/blood.V128.22.1086.1086

Published: 2016

Journal Articles

Bone Marrow Involvement Detected By Multi-Parameter Flow Cytometry Predicts Poor Outcome after Autologous Stem Cell Transplantation for Peripheral T-Cell Lymphoma

Jordan Gauthier, MDMSc, Leona Holmberg, MD PhD, David Wu, MD PhD, William I. Bensinger, MD, Ajay K. Gopal, MD, Oliver W. Press, MD PhD, David G Maloney, MD PhD, Damian J. Green, MD, Brian G. Till, MD, Denys Byelykh, MD, Andrei R. Shustov, MD

Blood (2015) 126 (23): 1972.

https://doi.org/10.1182/blood.V126.23.1972.1972

Published: 2015

Journal Articles

Robust Detection Of Minimal Residual Disease In Unselected Patients With B-Cell Precursor Acute Lymphoblastic Leukemia By High-Throughput Sequencing Of IGH

David Wu, MD, PhD, Ryan O Emerson, PhD, Anna Sherwood, PhD, Mignon L. Loh, MD, Anne Angiolillo, MD, Ilan Kirsch, MD, Christopher S Carlson, PhD, David Williamson, PhD, Brent L. Wood, MD, PhD, Harlan Robins, PhD

Blood (2013) 122 (21): 2550.

https://doi.org/10.1182/blood.V122.21.2550.2550

Published: 2013

Journal Articles

Detection Of Recurrent/Persistent Disease By T-Cell Receptor Repertoire Profiling In Patients With Mature T-Cell Neoplasm

Anna Sherwood, PhD, Harlan Robins, PhD, Jonathan R. Fromm, MD, PhD, Harvey A. Greisman, MD, PhD, Daniel E. Sabath, MD, PhD, Ryan O. Emerson, PhD, Mark J. Rieder, PhD, Brent L. Wood, MD, PhD, David Wu, MD, PhD

Blood (2013) 122 (21): 2614.

https://doi.org/10.1182/blood.V122.21.2614.2614

Published: 2013

Journal Articles

On-Going Evolution Of IGH In B-Cell Precursor Acute Lymphoblastic Leukemia Does Not Substantially Affect Day 29, Post-Treatment MRD Quantification By High-Throughput Sequencing

Blood (2013) 122 (21): 1341.

https://doi.org/10.1182/blood.V122.21.1341.1341

Published: 2013

Journal Articles

High-Throughput Sequencing of T-Cell Receptor Gene Loci for Minimal Residual Disease Monitoring in T Lymphoblastic Leukemia

David Wu, MD, PhD, Anna Sherwood, PhD, Stuart S. Winter, MD, Kimberly Dunsmore, MD, Mignon L Loh, MD, Jonathan R Fromm, MD, PhD, Harvey A Greisman, MD, PhD, Daniel E. Sabath, MD, PhD, Brent L. Wood, MD, PhD, Harlan Robins, PhD

Blood (2011) 118 (21): 2545.

https://doi.org/10.1182/blood.V118.21.2545.2545

Published: 2011

NARROW

Expert Curation of Somatic Variants in Hematological Malignancies By the Clingen Somatic Hematological Cancer Taskforce (ClinGen HCT)

Comparative Genomic Analyses Defines Shared and Unique Features of cHL and PMBL and New Mechanisms of Sensitivity to PD-1 Blockade

Comprehensive Evaluation and Validation of a Next-Generation Sequencing Assay for Minimal Residual Disease Detection in T-Lymphoblastic Leukemia/Lymphoma

Myeloid Malignancy Variant Curation Expert Panel: An ASH-Sponsored Clingen Expert Panel to Optimize and Validate Acmg/AMP Variant Interpretation Guidelines for Genes Associated with Inherited Myeloid Neoplasms

Comprehensive Genomic Analysis of Flow-Sorted Hodgkin Reed Sternberg Cells Reveals Additional Genetic Bases of Immune Evasion

Significance of Peri-Transplant Measurable Residual Disease Detected By Multiparameter Flow Cytometry and Next-Generation Sequencing in Adults with NPM1 -Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Detection of Mutations in Inherited Bone Marrow Failure and Myelodysplastic Syndrome Genes Using Genomic Capture and Massively Parallel Sequencing in Clinical Diagnostics

Residual Disease Monitoring By High Throughput Sequencing Provides Risk Stratification in Childhood B-ALL and Identifies a Novel Subset of Patients Having Poor Outcome

Bone Marrow Involvement Detected By Multi-Parameter Flow Cytometry Predicts Poor Outcome after Autologous Stem Cell Transplantation for Peripheral T-Cell Lymphoma

Robust Detection Of Minimal Residual Disease In Unselected Patients With B-Cell Precursor Acute Lymphoblastic Leukemia By High-Throughput Sequencing Of IGH

Detection Of Recurrent/Persistent Disease By T-Cell Receptor Repertoire Profiling In Patients With Mature T-Cell Neoplasm

On-Going Evolution Of IGH In B-Cell Precursor Acute Lymphoblastic Leukemia Does Not Substantially Affect Day 29, Post-Treatment MRD Quantification By High-Throughput Sequencing

High-Throughput Sequencing of T-Cell Receptor Gene Loci for Minimal Residual Disease Monitoring in T Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only